首页 > 最新文献

World Journal of Gastrointestinal Surgery最新文献

英文 中文
Impact of minimally invasive surgery on immune function and stress response in gastric cancer patients. 微创手术对胃癌患者免疫功能和应激反应的影响。
IF 1.8 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-27 DOI: 10.4240/wjgs.v16.i8.2484
Rong-Hua Zhu, Peng-Cheng Li, Jie Zhang, Hua-Hua Song

Background: Gastric cancer remains a leading cause of cancer-related mortality globally. Traditional open surgery for gastric cancer is often associated with significant morbidity and prolonged recovery.

Aim: To evaluate the effectiveness of laparoscopic minimally invasive surgery as an alternative to traditional open surgery for gastric cancer, focusing on its potential to reduce trauma, accelerate recovery, and achieve comparable oncological outcomes.

Methods: This study retrospectively analyzed 203 patients with gastric cancer who underwent surgery at the Shanghai Health Medical College Affiliated Chongming Hospital from January 2020 to December 2023. The patients were divided into two groups: Minimally invasive surgery group (n = 102), who underwent laparoscopic gastrectomy, and open surgery group (n = 101), who underwent traditional open gastrectomy. We compared surgical indicators (surgical incision size, intraoperative blood loss, surgical duration, and number of lymph nodes dissected), recovery parameters (time to first flatus, time to start eating, time to ambulation, and length of hospital stay), immune function (levels of IgA, IgG, and IgM), intestinal barrier function (levels of D-lactic acid and diamine oxidase), and stress response (levels of C-reactive protein, interleukin-6, and procalcitonin).

Results: The minimally invasive surgery group demonstrated significantly better outcomes in terms of surgical indicators, including smaller incisions, less blood loss, shorter surgery time, and more lymph nodes dissected (P < 0.05 for all). Recovery was also faster in the minimally invasive surgery group, with earlier return of bowel function, earlier initiation of diet, quicker mobilization, and shorter hospital stays (P < 0.05 for all). Furthermore, patients in the minimally invasive surgery group had better preserved immune function, superior intestinal barrier function, and a less pronounced stress response postoperatively (P < 0.05 for all).

Conclusion: Laparoscopic minimally invasive surgery for gastric cancer not only provides superior surgical indicators and faster recovery but also offers advantages in preserving immune function, protecting intestinal barrier function, and mitigating the stress response compared to traditional open surgery. These findings support the broader adoption of laparoscopic techniques in the management of gastric cancer.

背景:胃癌仍然是全球癌症相关死亡的主要原因。目的:评估腹腔镜微创手术替代传统开腹手术治疗胃癌的效果,重点关注腹腔镜微创手术在减少创伤、加速恢复和获得可比肿瘤学结果方面的潜力:本研究回顾性分析了2020年1月至2023年12月期间在上海健康医学院附属崇明医院接受手术治疗的203例胃癌患者。患者分为两组:微创手术组(102 人)接受腹腔镜胃切除术,开放手术组(101 人)接受传统开腹胃切除术。我们比较了手术指标(手术切口大小、术中失血量、手术时间和淋巴结清扫数量)、恢复参数(首次排便时间、开始进食时间、下地活动时间和住院时间)、免疫功能(IgA、IgG 和 IgM 水平)、肠屏障功能(D-乳酸和二胺氧化酶水平)和应激反应(C 反应蛋白、白细胞介素-6 和降钙素原水平):就手术指标而言,微创手术组的疗效明显更好,包括切口更小、失血更少、手术时间更短、切除的淋巴结更多(所有数据的P < 0.05)。微创手术组患者的恢复也更快,肠道功能恢复更早,更早开始进食,活动更快,住院时间更短(P < 0.05)。此外,微创手术组患者的免疫功能保存得更好,肠道屏障功能更优越,术后应激反应更不明显(所有数据的P < 0.05):结论:腹腔镜微创手术治疗胃癌不仅能提供更优越的手术指标和更快的恢复速度,而且与传统的开放式手术相比,腹腔镜微创手术在保护免疫功能、保护肠道屏障功能和减轻应激反应方面更具优势。这些研究结果支持在胃癌治疗中更广泛地采用腹腔镜技术。
{"title":"Impact of minimally invasive surgery on immune function and stress response in gastric cancer patients.","authors":"Rong-Hua Zhu, Peng-Cheng Li, Jie Zhang, Hua-Hua Song","doi":"10.4240/wjgs.v16.i8.2484","DOIUrl":"10.4240/wjgs.v16.i8.2484","url":null,"abstract":"<p><strong>Background: </strong>Gastric cancer remains a leading cause of cancer-related mortality globally. Traditional open surgery for gastric cancer is often associated with significant morbidity and prolonged recovery.</p><p><strong>Aim: </strong>To evaluate the effectiveness of laparoscopic minimally invasive surgery as an alternative to traditional open surgery for gastric cancer, focusing on its potential to reduce trauma, accelerate recovery, and achieve comparable oncological outcomes.</p><p><strong>Methods: </strong>This study retrospectively analyzed 203 patients with gastric cancer who underwent surgery at the Shanghai Health Medical College Affiliated Chongming Hospital from January 2020 to December 2023. The patients were divided into two groups: Minimally invasive surgery group (<i>n</i> = 102), who underwent laparoscopic gastrectomy, and open surgery group (<i>n</i> = 101), who underwent traditional open gastrectomy. We compared surgical indicators (surgical incision size, intraoperative blood loss, surgical duration, and number of lymph nodes dissected), recovery parameters (time to first flatus, time to start eating, time to ambulation, and length of hospital stay), immune function (levels of IgA, IgG, and IgM), intestinal barrier function (levels of D-lactic acid and diamine oxidase), and stress response (levels of C-reactive protein, interleukin-6, and procalcitonin).</p><p><strong>Results: </strong>The minimally invasive surgery group demonstrated significantly better outcomes in terms of surgical indicators, including smaller incisions, less blood loss, shorter surgery time, and more lymph nodes dissected (<i>P</i> < 0.05 for all). Recovery was also faster in the minimally invasive surgery group, with earlier return of bowel function, earlier initiation of diet, quicker mobilization, and shorter hospital stays (<i>P</i> < 0.05 for all). Furthermore, patients in the minimally invasive surgery group had better preserved immune function, superior intestinal barrier function, and a less pronounced stress response postoperatively (<i>P</i> < 0.05 for all).</p><p><strong>Conclusion: </strong>Laparoscopic minimally invasive surgery for gastric cancer not only provides superior surgical indicators and faster recovery but also offers advantages in preserving immune function, protecting intestinal barrier function, and mitigating the stress response compared to traditional open surgery. These findings support the broader adoption of laparoscopic techniques in the management of gastric cancer.</p>","PeriodicalId":23759,"journal":{"name":"World Journal of Gastrointestinal Surgery","volume":"16 8","pages":"2484-2493"},"PeriodicalIF":1.8,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11362953/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142112678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lone-Star retractor perineal exposure method for laparoscopic abdominal perineal resection of rectal cancer. 用于直肠癌腹腔镜会阴切除术的 Lone-Star 牵引器会阴暴露法。
IF 1.8 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-27 DOI: 10.4240/wjgs.v16.i8.2528
Jun Ma, Dai-Bin Tang, Yu-Quan Tang, Da-Tian Wang, Peng Jiang, Ya-Ming Zhang

Background: The abdominal perineal resection (APR), historically referred to as Mile's procedure, stands as a time-honored surgical intervention for rectal cancer management. Advancements in surgical techniques and the advent of neoadjuvant therapies have significantly improved the rate of sphincter preservation among patients afflicted with rectal cancer, including those with ultralow rectal cancer. Despite these improvements, APR maintains its irreplaceable role in the clinical landscape, particularly for cases involving low rectal cancer with encroachment on the external anal sphincter or levator ani muscles. Optimal perineal exposure stands as a pivotal phase in APR, given that the precision of this maneuver is directly correlated with both the safety of the surgery and the patient's subsequent long-term prognosis.

Aim: To evaluate the value of Lone-Star retractor (LSR) perineal exposure method in the treatment for laparoscopic APR of rectal cancer.

Methods: We reviewed the records of 38 patients with rectal cancer at Anqing Municipal Hospital from January 2020 to December 2023, including 20 patients who underwent the APR procedure with a LSR perineal exposure method (LSR group) and 18 patients who underwent the APR procedure with a conventional perineal exposure method (control group). In the LSR group, following incision of the skin and subcutaneous tissue, the LSR was placed and dynamically adjusted according to the surgical plane to fully expose the perineal operative field.

Results: A total of 38 patients underwent laparoscopic APR, none of whom were found to have distant metastasis upon intraoperative exploration. Perineal blood loss, the postoperative hospital stays and the wound pain scores in the LSR group were significantly lower than those in the control group. A single surgeon completed the perineal operation significantly more often in the LSR group than in the control group (P < 0.05). The incidence of infection via the perineal incision in the LSR group was significantly lower than that in the control group (P < 0.05). No cases of distant metastasis or local recurrence were found among the patients at the postoperative follow-up.

Conclusion: The application of the LSR technique might be helpful for performing perineal exposure during APR for rectal cancer and could reduce the incidence of perineal complications, shorten the postoperative hospital stay, improve postoperative pain, and allow one surgeon to perform the perineal operation.

背景:腹会阴切除术(APR)在历史上被称为米勒手术,是一种历史悠久的直肠癌手术治疗方法。手术技术的进步和新辅助疗法的出现大大提高了直肠癌患者(包括超低位直肠癌患者)的括约肌保留率。尽管取得了这些进步,但 APR 仍在临床中发挥着不可替代的作用,尤其是对于侵犯肛门外括约肌或提肛肌的低位直肠癌病例。最佳会阴暴露是腹腔镜直肠癌切除术的关键阶段,因为这一操作的精确性直接关系到手术的安全性和患者随后的长期预后:回顾性分析安庆市立医院2020年1月至2023年12月收治的38例直肠癌患者的病历,其中20例患者接受了LSR会阴暴露法腹腔镜直肠癌切除术(LSR组),18例患者接受了传统会阴暴露法腹腔镜直肠癌切除术(对照组)。在LSR组中,切开皮肤和皮下组织后,放置LSR并根据手术平面动态调整,以充分暴露会阴手术区域:结果:共有 38 名患者接受了腹腔镜 APR,术中探查时均未发现远处转移。LSR组的会阴失血量、术后住院时间和伤口疼痛评分均明显低于对照组。LSR组由一名外科医生完成会阴手术的比例明显高于对照组(P < 0.05)。LSR组经由会阴切口感染的发生率明显低于对照组(P < 0.05)。术后随访中未发现远处转移或局部复发病例:结论:LSR技术的应用可能有助于在直肠癌APR术中进行会阴部暴露,可降低会阴部并发症的发生率,缩短术后住院时间,改善术后疼痛,并可由一名外科医生进行会阴部手术。
{"title":"Lone-Star retractor perineal exposure method for laparoscopic abdominal perineal resection of rectal cancer.","authors":"Jun Ma, Dai-Bin Tang, Yu-Quan Tang, Da-Tian Wang, Peng Jiang, Ya-Ming Zhang","doi":"10.4240/wjgs.v16.i8.2528","DOIUrl":"10.4240/wjgs.v16.i8.2528","url":null,"abstract":"<p><strong>Background: </strong>The abdominal perineal resection (APR), historically referred to as Mile's procedure, stands as a time-honored surgical intervention for rectal cancer management. Advancements in surgical techniques and the advent of neoadjuvant therapies have significantly improved the rate of sphincter preservation among patients afflicted with rectal cancer, including those with ultralow rectal cancer. Despite these improvements, APR maintains its irreplaceable role in the clinical landscape, particularly for cases involving low rectal cancer with encroachment on the external anal sphincter or levator ani muscles. Optimal perineal exposure stands as a pivotal phase in APR, given that the precision of this maneuver is directly correlated with both the safety of the surgery and the patient's subsequent long-term prognosis.</p><p><strong>Aim: </strong>To evaluate the value of Lone-Star retractor (LSR) perineal exposure method in the treatment for laparoscopic APR of rectal cancer.</p><p><strong>Methods: </strong>We reviewed the records of 38 patients with rectal cancer at Anqing Municipal Hospital from January 2020 to December 2023, including 20 patients who underwent the APR procedure with a LSR perineal exposure method (LSR group) and 18 patients who underwent the APR procedure with a conventional perineal exposure method (control group). In the LSR group, following incision of the skin and subcutaneous tissue, the LSR was placed and dynamically adjusted according to the surgical plane to fully expose the perineal operative field.</p><p><strong>Results: </strong>A total of 38 patients underwent laparoscopic APR, none of whom were found to have distant metastasis upon intraoperative exploration. Perineal blood loss, the postoperative hospital stays and the wound pain scores in the LSR group were significantly lower than those in the control group. A single surgeon completed the perineal operation significantly more often in the LSR group than in the control group (<i>P</i> < 0.05). The incidence of infection <i>via</i> the perineal incision in the LSR group was significantly lower than that in the control group (<i>P</i> < 0.05). No cases of distant metastasis or local recurrence were found among the patients at the postoperative follow-up.</p><p><strong>Conclusion: </strong>The application of the LSR technique might be helpful for performing perineal exposure during APR for rectal cancer and could reduce the incidence of perineal complications, shorten the postoperative hospital stay, improve postoperative pain, and allow one surgeon to perform the perineal operation.</p>","PeriodicalId":23759,"journal":{"name":"World Journal of Gastrointestinal Surgery","volume":"16 8","pages":"2528-2537"},"PeriodicalIF":1.8,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11362942/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142112681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nomogram predicting the prognosis of primary liver cancer after radiofrequency ablation combined with transcatheter arterial chemoembolization. 预测射频消融联合经导管动脉化疗栓塞术后原发性肝癌预后的提名图。
IF 1.8 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-27 DOI: 10.4240/wjgs.v16.i8.2630
Hai-Hua Shen, Yu-Rong Hong, Wen Xu, Lei Chen, Jun-Min Chen, Zhi-Gen Yang, Cai-Hong Chen

Background: The incidence and mortality rates of primary hepatocellular carcinoma (HCC) are high, and the conventional treatment is radiofrequency ablation (RFA) with transcatheter arterial chemoembolization (TACE); however, the 3-year survival rate is still low. Further, there are no visual methods to effectively predict their prognosis.

Aim: To explore the factors influencing the prognosis of HCC after RFA and TACE and develop a nomogram prediction model.

Methods: Clinical and follow-up information of 150 patients with HCC treated using RFA and TACE in the Hangzhou Linping Hospital of Traditional Chinese Medicine from May 2020 to December 2022 was retrospectively collected and recorded. We examined their prognostic factors using multivariate logistic regression and created a nomogram prognosis prediction model using the R software (version 4.1.2). Internal verification was performed using the bootstrapping technique. The prognostic efficacy of the nomogram prediction model was evaluated using the concordance index (CI), calibration curve, and receiver operating characteristic curve.

Results: Of the 150 patients treated with RFA and TACE, 92 (61.33%) developed recurrence and metastasis. Logistic regression analysis identified six variables, and a predictive model was created. The internal validation results of the model showed a CI of 0.882. The correction curve trend of the prognosis prediction model was always near the diagonal, and the mean absolute error before and after internal validation was 0.021. The area under the curve of the prediction model after internal verification was 0.882 [95% confidence interval (95%CI): 0.820-0.945], with a specificity of 0.828 and sensitivity of 0.656. According to the Hosmer-Lemeshow test, χ 2 = 3.552 and P = 0.895. The predictive model demonstrated a satisfactory calibration, and the decision curve analysis demonstrated its clinical applicability.

Conclusion: The prognosis of patients with HCC after RFA and TACE is affected by several factors. The developed prediction model based on the influencing parameters shows a good prognosis predictive efficacy.

背景:原发性肝细胞癌(HCC)的发病率和死亡率都很高,常规治疗方法是射频消融(RFA)和经导管动脉化疗栓塞(TACE),但3年生存率仍然很低。目的:探讨RFA和TACE术后HCC预后的影响因素,并建立提名图预测模型:方法:回顾性收集并记录2020年5月至2022年12月在杭州市临平中医院接受RFA和TACE治疗的150例HCC患者的临床和随访资料。我们使用多元逻辑回归分析了这些患者的预后因素,并使用 R 软件(4.1.2 版)创建了一个提名图预后预测模型。我们使用引导技术进行了内部验证。使用一致性指数(CI)、校准曲线和接收者操作特征曲线评估了提名图预测模型的预后效果:在接受 RFA 和 TACE 治疗的 150 例患者中,92 例(61.33%)出现复发和转移。逻辑回归分析确定了六个变量,并建立了一个预测模型。模型的内部验证结果显示 CI 为 0.882。预后预测模型的校正曲线趋势始终在对角线附近,内部验证前后的平均绝对误差为 0.021。内部验证后预测模型的曲线下面积为 0.882 [95%置信区间(95%CI):0.820-0.945],特异性为 0.828,灵敏度为 0.656。根据 Hosmer-Lemeshow 检验,χ 2 = 3.552,P = 0.895。预测模型的校准结果令人满意,决策曲线分析表明了其临床适用性:结论:经过 RFA 和 TACE 治疗的 HCC 患者的预后受到多种因素的影响。根据影响参数建立的预测模型显示出良好的预后预测效果。
{"title":"Nomogram predicting the prognosis of primary liver cancer after radiofrequency ablation combined with transcatheter arterial chemoembolization.","authors":"Hai-Hua Shen, Yu-Rong Hong, Wen Xu, Lei Chen, Jun-Min Chen, Zhi-Gen Yang, Cai-Hong Chen","doi":"10.4240/wjgs.v16.i8.2630","DOIUrl":"10.4240/wjgs.v16.i8.2630","url":null,"abstract":"<p><strong>Background: </strong>The incidence and mortality rates of primary hepatocellular carcinoma (HCC) are high, and the conventional treatment is radiofrequency ablation (RFA) with transcatheter arterial chemoembolization (TACE); however, the 3-year survival rate is still low. Further, there are no visual methods to effectively predict their prognosis.</p><p><strong>Aim: </strong>To explore the factors influencing the prognosis of HCC after RFA and TACE and develop a nomogram prediction model.</p><p><strong>Methods: </strong>Clinical and follow-up information of 150 patients with HCC treated using RFA and TACE in the Hangzhou Linping Hospital of Traditional Chinese Medicine from May 2020 to December 2022 was retrospectively collected and recorded. We examined their prognostic factors using multivariate logistic regression and created a nomogram prognosis prediction model using the R software (version 4.1.2). Internal verification was performed using the bootstrapping technique. The prognostic efficacy of the nomogram prediction model was evaluated using the concordance index (CI), calibration curve, and receiver operating characteristic curve.</p><p><strong>Results: </strong>Of the 150 patients treated with RFA and TACE, 92 (61.33%) developed recurrence and metastasis. Logistic regression analysis identified six variables, and a predictive model was created. The internal validation results of the model showed a CI of 0.882. The correction curve trend of the prognosis prediction model was always near the diagonal, and the mean absolute error before and after internal validation was 0.021. The area under the curve of the prediction model after internal verification was 0.882 [95% confidence interval (95%CI): 0.820-0.945], with a specificity of 0.828 and sensitivity of 0.656. According to the Hosmer-Lemeshow test, <i>χ</i> <sup>2</sup> = 3.552 and <i>P</i> = 0.895. The predictive model demonstrated a satisfactory calibration, and the decision curve analysis demonstrated its clinical applicability.</p><p><strong>Conclusion: </strong>The prognosis of patients with HCC after RFA and TACE is affected by several factors. The developed prediction model based on the influencing parameters shows a good prognosis predictive efficacy.</p>","PeriodicalId":23759,"journal":{"name":"World Journal of Gastrointestinal Surgery","volume":"16 8","pages":"2630-2639"},"PeriodicalIF":1.8,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11362921/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142112686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Benefits of jejunostomy feeding in patients who underwent gastrectomy for cancer treatment. 因癌症接受胃切除术的患者空肠造口喂养的好处。
IF 1.8 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-27 DOI: 10.4240/wjgs.v16.i8.2461
Romain Jaquet, Emmanuel Rivkine, Nicole De Souza, Jean Roudié

Background: Gastric cancer is associated with significant undernutrition responsible for an increase in morbidity and mortality after gastrectomy.

Aim: To evaluate the impact of enteral nutrition by jejunostomy feeding in patients undergoing gastrectomy for cancer.

Methods: Between 2003 and 2017, all patients undergoing gastrectomy for cancer treatment were included retrospectively. A group with jejunostomy (J + group) and a group without jejunostomy (J - group) were compared.

Results: Of the 172 patients included, 60 received jejunostomy. Preoperatively, the two groups were comparable with respect to the nutritional parameters studied (body mass index, albumin, etc.). In the postoperative period, the J + group lost less weight and albumin: 5.74 ± 8.4 vs 9.86 ± 7.5 kg (P = 0.07) and 7.2 ± 5.6 vs 14.7 ± 12.7 g/L (P = 0.16), respectively. Overall morbidity was 25% in the J + group and 36.6% in the J - group (P = 0.12). The J + group had fewer respiratory, infectious, and grade 3 complications: 0% vs 5.4% (P = 0.09), 1.2% vs 9.3% (P = 0.03), and 0% vs 4.7% (P = 0.05), respectively. The 30-day mortality was 6.7% in the J + group and 6.3% in the J - group (P = 0.91).

Conclusion: Jejunostomy feeding after gastrectomy improves nutritional characteristics and decreases postoperative morbidity. A prospective study could confirm our results.

背景:目的:评估空肠造口术肠内营养对癌症胃切除术患者的影响:方法:回顾性纳入2003年至2017年期间因癌症接受胃切除术治疗的所有患者。结果:在纳入的 172 名患者中,有 60 人接受了空肠造口术(J + 组):结果:在纳入的 172 例患者中,有 60 例接受了空肠造口术。术前,两组患者的营养指标(体重指数、白蛋白等)相当。术后,J + 组的体重和白蛋白损失较少:分别为 5.74 ± 8.4 对 9.86 ± 7.5 公斤(P = 0.07)和 7.2 ± 5.6 对 14.7 ± 12.7 克/升(P = 0.16)。J + 组的总发病率为 25%,J - 组为 36.6%(P = 0.12)。J + 组的呼吸道、感染和 3 级并发症较少:分别为 0% vs 5.4% (P = 0.09)、1.2% vs 9.3% (P = 0.03) 和 0% vs 4.7% (P = 0.05)。J+组的30天死亡率为6.7%,J-组为6.3%(P = 0.91):结论:胃切除术后进行空肠造口喂养可改善营养状况,降低术后发病率。前瞻性研究可证实我们的结果。
{"title":"Benefits of jejunostomy feeding in patients who underwent gastrectomy for cancer treatment.","authors":"Romain Jaquet, Emmanuel Rivkine, Nicole De Souza, Jean Roudié","doi":"10.4240/wjgs.v16.i8.2461","DOIUrl":"10.4240/wjgs.v16.i8.2461","url":null,"abstract":"<p><strong>Background: </strong>Gastric cancer is associated with significant undernutrition responsible for an increase in morbidity and mortality after gastrectomy.</p><p><strong>Aim: </strong>To evaluate the impact of enteral nutrition by jejunostomy feeding in patients undergoing gastrectomy for cancer.</p><p><strong>Methods: </strong>Between 2003 and 2017, all patients undergoing gastrectomy for cancer treatment were included retrospectively. A group with jejunostomy (J + group) and a group without jejunostomy (J - group) were compared.</p><p><strong>Results: </strong>Of the 172 patients included, 60 received jejunostomy. Preoperatively, the two groups were comparable with respect to the nutritional parameters studied (body mass index, albumin, <i>etc.</i>). In the postoperative period, the J + group lost less weight and albumin: 5.74 ± 8.4 <i>vs</i> 9.86 ± 7.5 kg (<i>P</i> = 0.07) and 7.2 ± 5.6 <i>vs</i> 14.7 ± 12.7 g/L (<i>P</i> = 0.16), respectively. Overall morbidity was 25% in the J + group and 36.6% in the J - group (<i>P</i> = 0.12). The J + group had fewer respiratory, infectious, and grade 3 complications: 0% <i>vs</i> 5.4% (<i>P</i> = 0.09), 1.2% <i>vs</i> 9.3% (<i>P</i> = 0.03), and 0% <i>vs</i> 4.7% (<i>P</i> = 0.05), respectively. The 30-day mortality was 6.7% in the J + group and 6.3% in the J - group (<i>P</i> = 0.91).</p><p><strong>Conclusion: </strong>Jejunostomy feeding after gastrectomy improves nutritional characteristics and decreases postoperative morbidity. A prospective study could confirm our results.</p>","PeriodicalId":23759,"journal":{"name":"World Journal of Gastrointestinal Surgery","volume":"16 8","pages":"2461-2473"},"PeriodicalIF":1.8,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11362917/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142112655","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical application value of long non-coding RNAs signatures of genomic instability in predicting prognosis of hepatocellular carcinoma. 长非编码 RNA 基因组不稳定性特征在预测肝细胞癌预后中的临床应用价值。
IF 1.8 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-27 DOI: 10.4240/wjgs.v16.i8.2386
Xiao-Wen Xing, Xiao Huang, Wei-Peng Li, Ming-Ke Wang, Ji-Shun Yang

Hepatocellular carcinoma (HCC) presents challenges due to its high recurrence and metastasis rates and poor prognosis. While current clinical diagnostic and prognostic indicators exist, their accuracy remains imperfect due to their biological complexity. Therefore, there is a quest to identify improved biomarkers for HCC diagnosis and prognosis. By combining long non-coding RNA (lncRNA) expression and somatic mutations, Duan et al identified five representative lncRNAs from 88 lncRNAs related to genomic instability (GI), forming a GI-derived lncRNA signature (LncSig). This signature outperforms previously reported LncSig and TP53 mutations in predicting HCC prognosis. In this editorial, we comprehensively evaluate the clinical application value of such prognostic evaluation model based on sequencing technology in terms of cost, time, and practicability. Additionally, we provide an overview of various prognostic models for HCC, aiding in a comprehensive understanding of research progress in prognostic evaluation methods.

肝细胞癌(HCC)复发率高、转移率高、预后差,这给我们带来了挑战。虽然目前已有临床诊断和预后指标,但由于其生物学复杂性,其准确性仍不尽如人意。因此,人们一直在寻找更好的生物标志物来诊断 HCC 和预后。通过结合长非编码RNA(lncRNA)的表达和体细胞突变,Duan等人从88个与基因组不稳定性(GI)相关的lncRNA中鉴定出了5个具有代表性的lncRNA,形成了GI衍生的lncRNA特征(LncSig)。该特征在预测 HCC 预后方面优于之前报道的 LncSig 和 TP53 突变。在这篇社论中,我们从成本、时间和实用性等方面全面评估了这种基于测序技术的预后评估模型的临床应用价值。此外,我们还概述了各种 HCC 预后模型,有助于全面了解预后评估方法的研究进展。
{"title":"Clinical application value of long non-coding RNAs signatures of genomic instability in predicting prognosis of hepatocellular carcinoma.","authors":"Xiao-Wen Xing, Xiao Huang, Wei-Peng Li, Ming-Ke Wang, Ji-Shun Yang","doi":"10.4240/wjgs.v16.i8.2386","DOIUrl":"10.4240/wjgs.v16.i8.2386","url":null,"abstract":"<p><p>Hepatocellular carcinoma (HCC) presents challenges due to its high recurrence and metastasis rates and poor prognosis. While current clinical diagnostic and prognostic indicators exist, their accuracy remains imperfect due to their biological complexity. Therefore, there is a quest to identify improved biomarkers for HCC diagnosis and prognosis. By combining long non-coding RNA (lncRNA) expression and somatic mutations, Duan <i>et al</i> identified five representative lncRNAs from 88 lncRNAs related to genomic instability (GI), forming a GI-derived lncRNA signature (LncSig). This signature outperforms previously reported LncSig and TP53 mutations in predicting HCC prognosis. In this editorial, we comprehensively evaluate the clinical application value of such prognostic evaluation model based on sequencing technology in terms of cost, time, and practicability. Additionally, we provide an overview of various prognostic models for HCC, aiding in a comprehensive understanding of research progress in prognostic evaluation methods.</p>","PeriodicalId":23759,"journal":{"name":"World Journal of Gastrointestinal Surgery","volume":"16 8","pages":"2386-2392"},"PeriodicalIF":1.8,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11362949/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142112656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultrasound-guided peripheral nerve blocks for anterior cutaneous nerve entrapment syndrome after robot-assisted gastrectomy: A case report. 超声引导下外周神经阻滞治疗机器人辅助胃切除术后前皮神经卡压综合征:病例报告。
IF 1.8 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-27 DOI: 10.4240/wjgs.v16.i8.2719
Yukiko Saito, Hirohisa Takeuchi, Joho Tokumine, Ryuji Sawada, Kunitaro Watanabe, Tomoko Yorozu

Background: Anterior cutaneous nerve entrapment syndrome (ACNES) is a condition manifesting with pain caused by strangulation of the anterior cutaneous branch of the lower intercostal nerves. This case report aims to provide new insight into the selection of peripheral nerve blocks for the ACNES treatment.

Case summary: A 66-year-old woman manifested ACNES after a robot-assisted distal gastrectomy. An ultrasound-guided rectal sheath block was effective for pain triggered by the port scar. However, the sudden severe pain, which radiated laterally from the previous site, remained. A transversus abdominis plane block was performed for the remaining pain and effectively relieved it.

Conclusion: In this case, the trocar port was inserted between the rectus and transverse abdominis muscles. The intercostal nerves might have been entrapped on both sides of the rectus and transversus abdominis muscles. Hence, rectus sheath and transverse abdominis plane blocks were required to achieve complete pain relief. To the best of our knowledge, this is the first report on use of a combination of rectus sheath and transverse abdominis plane blocks for pain relief in ACNES.

背景:前皮神经卡压综合征(ACNES)是一种因肋间下神经前皮支受压而引起疼痛的疾病。本病例报告旨在为选择外周神经阻滞治疗 ACNES 提供新的见解。病例摘要:一名 66 岁的女性在接受机器人辅助远端胃切除术后出现 ACNES。超声引导下的直肠鞘阻滞对端口疤痕引发的疼痛有效。然而,突然出现的剧烈疼痛依然存在,并从先前的部位向侧方放射。对剩余的疼痛进行了腹横肌平面阻滞,有效缓解了疼痛:在这个病例中,套管口插入了腹直肌和腹横肌之间。结论:该病例的套管口插入腹直肌和腹横肌之间,肋间神经可能被夹在腹直肌和腹横肌两侧。因此,需要进行直肌鞘和腹横肌平面阻滞,以达到完全止痛的目的。据我们所知,这是第一例使用腹直肌鞘和腹横肌平面联合阻滞来缓解 ACNES 疼痛的报告。
{"title":"Ultrasound-guided peripheral nerve blocks for anterior cutaneous nerve entrapment syndrome after robot-assisted gastrectomy: A case report.","authors":"Yukiko Saito, Hirohisa Takeuchi, Joho Tokumine, Ryuji Sawada, Kunitaro Watanabe, Tomoko Yorozu","doi":"10.4240/wjgs.v16.i8.2719","DOIUrl":"10.4240/wjgs.v16.i8.2719","url":null,"abstract":"<p><strong>Background: </strong>Anterior cutaneous nerve entrapment syndrome (ACNES) is a condition manifesting with pain caused by strangulation of the anterior cutaneous branch of the lower intercostal nerves. This case report aims to provide new insight into the selection of peripheral nerve blocks for the ACNES treatment.</p><p><strong>Case summary: </strong>A 66-year-old woman manifested ACNES after a robot-assisted distal gastrectomy. An ultrasound-guided rectal sheath block was effective for pain triggered by the port scar. However, the sudden severe pain, which radiated laterally from the previous site, remained. A transversus abdominis plane block was performed for the remaining pain and effectively relieved it.</p><p><strong>Conclusion: </strong>In this case, the trocar port was inserted between the rectus and transverse abdominis muscles. The intercostal nerves might have been entrapped on both sides of the rectus and transversus abdominis muscles. Hence, rectus sheath and transverse abdominis plane blocks were required to achieve complete pain relief. To the best of our knowledge, this is the first report on use of a combination of rectus sheath and transverse abdominis plane blocks for pain relief in ACNES.</p>","PeriodicalId":23759,"journal":{"name":"World Journal of Gastrointestinal Surgery","volume":"16 8","pages":"2719-2723"},"PeriodicalIF":1.8,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11362933/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142112698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond total mesorectal excision: The emerging role of minimally invasive surgery for locally advanced rectal cancer. 超越全直肠系膜切除术:微创手术对局部晚期直肠癌的新作用。
IF 1.8 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-27 DOI: 10.4240/wjgs.v16.i8.2382
Davina Perini, Francesca Cammelli, Maximilian Scheiterle, Jacopo Martellucci, Annamaria Di Bella, Carlo Bergamini, Paolo Prosperi, Alessio Giordano

Multivisceral resection and/or pelvic exenteration represents the only potential curative treatment for locally advanced rectal cancer (LARC); however, it poses significant technical challenges, which account for the high risk of morbidity and mortality associated with the procedure. As complete histopathologic resection is the most important determinant of patient outcomes, LARC often requires an extended resection beyond the total mesorectal excision plane to obtain clear resection margins. In an era when laparoscopic surgery and robot-assisted surgery are becoming commonplace, the optimal approach to extensive pelvic interventions remains controversial. However, acceptance of the suitability of minimally invasive surgery is slowly gaining traction. Nonetheless, there is still a lack of evidence in the literature about minimally invasive approaches in multiple and extensive surgical resections, highlighting the need for research studies to explore, validate, and develop this issue. This editorial aims to provide a critical overview of the currently available applications and challenges of minimally invasive abdominopelvic surgery for LARC. Furthermore, we discuss recent developments in the field of robotic surgery for LARC, with a specific focus on new innovations and emerging frontiers.

多脏器切除术和/或盆腔腹腔穿刺术是治疗局部晚期直肠癌(LARC)的唯一可行的根治方法;然而,这种方法在技术上存在很大的挑战,这也是造成该手术发病率和死亡率居高不下的原因。由于完整的组织病理学切除是决定患者预后的最重要因素,因此 LARC 通常需要将切除范围扩大到整个直肠系膜切除平面以外,以获得清晰的切除边缘。在腹腔镜手术和机器人辅助手术逐渐普及的今天,盆腔广泛介入手术的最佳方法仍存在争议。不过,微创手术的适用性正逐渐得到认可。尽管如此,文献中仍缺乏关于微创方法在多发性和广泛性手术切除中的应用的证据,这凸显了研究探索、验证和发展这一问题的必要性。本社论旨在对 LARC 微创腹盆腔手术的现有应用和挑战进行批判性概述。此外,我们还讨论了 LARC 机器人手术领域的最新发展,特别关注新的创新和新兴前沿领域。
{"title":"Beyond total mesorectal excision: The emerging role of minimally invasive surgery for locally advanced rectal cancer.","authors":"Davina Perini, Francesca Cammelli, Maximilian Scheiterle, Jacopo Martellucci, Annamaria Di Bella, Carlo Bergamini, Paolo Prosperi, Alessio Giordano","doi":"10.4240/wjgs.v16.i8.2382","DOIUrl":"10.4240/wjgs.v16.i8.2382","url":null,"abstract":"<p><p>Multivisceral resection and/or pelvic exenteration represents the only potential curative treatment for locally advanced rectal cancer (LARC); however, it poses significant technical challenges, which account for the high risk of morbidity and mortality associated with the procedure. As complete histopathologic resection is the most important determinant of patient outcomes, LARC often requires an extended resection beyond the total mesorectal excision plane to obtain clear resection margins. In an era when laparoscopic surgery and robot-assisted surgery are becoming commonplace, the optimal approach to extensive pelvic interventions remains controversial. However, acceptance of the suitability of minimally invasive surgery is slowly gaining traction. Nonetheless, there is still a lack of evidence in the literature about minimally invasive approaches in multiple and extensive surgical resections, highlighting the need for research studies to explore, validate, and develop this issue. This editorial aims to provide a critical overview of the currently available applications and challenges of minimally invasive abdominopelvic surgery for LARC. Furthermore, we discuss recent developments in the field of robotic surgery for LARC, with a specific focus on new innovations and emerging frontiers.</p>","PeriodicalId":23759,"journal":{"name":"World Journal of Gastrointestinal Surgery","volume":"16 8","pages":"2382-2385"},"PeriodicalIF":1.8,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11362916/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142117085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancements in nutritional diagnosis and support strategies during the perioperative period for patients with liver cancer. 肝癌患者围手术期营养诊断和支持策略的进展。
IF 1.8 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-27 DOI: 10.4240/wjgs.v16.i8.2409
Xiao-Qin Li, Yun Liang, Chen-Feng Huang, Sui-Ning Li, Lei Cheng, Chuan You, Yao-Xia Liu, Tao Wang

Liver cancer represents a grave hepatic condition and constitutes a significant global health concern. Surgical resection remains the principal therapeutic modality for liver cancer. Nevertheless, perioperative malnutrition exerts a notable impact on patients with liver cancer, emerging as an independent risk factor for disease mortality and adverse outcomes. Hence, precise nutritional diagnosis and timely nutritional support hold the potential to enhance therapeutic efficacy and quality of life for liver cancer patients. This study represents a meticulous foray into the literature, extracting data from PubMed, Web of Science, and EMBASE databases, with a focus on the past 5 years. It scrutinizes the impact of malnutrition on patients undergoing liver cancer surgery, the etiological underpinnings of malnutrition within this patient cohort, the critical assessment of perioperative nutritional status, and the strategic approaches to nutritional support. Utilizing rigorous inclusion and exclusion criteria, the amassed scholarly works are meticulously synthesized, methodically organized, and categorically elaborated upon. Ultimately, the authors propose the incorporation of a multidisciplinary nutrition management team during the perioperative period, comprising nutritionists, pharmacists, physicians, nurses, psychologists, and rehabilitation therapists, among other specialized professionals. Together, they collaborate to devise and implement personalized nutritional support plans, monitor patients' nutritional status, and make necessary adjustments as required. Through comprehensive management and intervention, improvements in the nutritional status of liver cancer patients can be achieved, thereby enhancing surgical success rates and facilitating postoperative recovery. It is believed that this manuscript will offer valuable insights to advance the nutritional management during the perioperative phase of liver cancer, aiding in ameliorating patients' nutritional status and treatment outcomes.

肝癌是一种严重的肝病,是全球关注的重大健康问题。手术切除仍是肝癌的主要治疗方式。然而,围手术期营养不良对肝癌患者的影响非常明显,是导致患者死亡和不良预后的独立风险因素。因此,精确的营养诊断和及时的营养支持有可能提高肝癌患者的治疗效果和生活质量。本研究从 PubMed、Web of Science 和 EMBASE 数据库中提取数据,以过去 5 年为重点,对文献进行了细致的研究。它仔细研究了营养不良对肝癌手术患者的影响、这类患者营养不良的病因、围手术期营养状况的关键评估以及营养支持的策略方法。作者采用严格的纳入和排除标准,对所收集的学术著作进行了细致的归纳、有条不紊的组织和分类阐述。最后,作者建议在围手术期组建一个多学科营养管理团队,由营养学家、药剂师、医生、护士、心理学家和康复治疗师等专业人员组成。他们共同合作,制定并实施个性化的营养支持计划,监测患者的营养状况,并根据需要做出必要的调整。通过综合管理和干预,可以改善肝癌患者的营养状况,从而提高手术成功率,促进术后恢复。相信这篇手稿将为推进肝癌围手术期的营养管理提供有价值的见解,有助于改善患者的营养状况和治疗效果。
{"title":"Advancements in nutritional diagnosis and support strategies during the perioperative period for patients with liver cancer.","authors":"Xiao-Qin Li, Yun Liang, Chen-Feng Huang, Sui-Ning Li, Lei Cheng, Chuan You, Yao-Xia Liu, Tao Wang","doi":"10.4240/wjgs.v16.i8.2409","DOIUrl":"10.4240/wjgs.v16.i8.2409","url":null,"abstract":"<p><p>Liver cancer represents a grave hepatic condition and constitutes a significant global health concern. Surgical resection remains the principal therapeutic modality for liver cancer. Nevertheless, perioperative malnutrition exerts a notable impact on patients with liver cancer, emerging as an independent risk factor for disease mortality and adverse outcomes. Hence, precise nutritional diagnosis and timely nutritional support hold the potential to enhance therapeutic efficacy and quality of life for liver cancer patients. This study represents a meticulous foray into the literature, extracting data from PubMed, Web of Science, and EMBASE databases, with a focus on the past 5 years. It scrutinizes the impact of malnutrition on patients undergoing liver cancer surgery, the etiological underpinnings of malnutrition within this patient cohort, the critical assessment of perioperative nutritional status, and the strategic approaches to nutritional support. Utilizing rigorous inclusion and exclusion criteria, the amassed scholarly works are meticulously synthesized, methodically organized, and categorically elaborated upon. Ultimately, the authors propose the incorporation of a multidisciplinary nutrition management team during the perioperative period, comprising nutritionists, pharmacists, physicians, nurses, psychologists, and rehabilitation therapists, among other specialized professionals. Together, they collaborate to devise and implement personalized nutritional support plans, monitor patients' nutritional status, and make necessary adjustments as required. Through comprehensive management and intervention, improvements in the nutritional status of liver cancer patients can be achieved, thereby enhancing surgical success rates and facilitating postoperative recovery. It is believed that this manuscript will offer valuable insights to advance the nutritional management during the perioperative phase of liver cancer, aiding in ameliorating patients' nutritional status and treatment outcomes.</p>","PeriodicalId":23759,"journal":{"name":"World Journal of Gastrointestinal Surgery","volume":"16 8","pages":"2409-2425"},"PeriodicalIF":1.8,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11362955/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142112636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of 18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging in recurrent anastomotic tumors after surgery in digestive tract tumors. 18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描成像在消化道肿瘤术后复发吻合口肿瘤中的应用。
IF 1.8 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-27 DOI: 10.4240/wjgs.v16.i8.2474
Deng-Feng Ge, Hao Ren, Zi-Chen Yang, Shou-Xiang Zhao, Zhen-Ting Cheng, Da-Da Wu, Bin Zhang
<p><strong>Background: </strong>This study was to investigate the application value of whole-body dynamic <sup>18</sup>F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) imaging in recurrent anastomotic tumors of digestive tract after gastric and esophageal cancer surgery. Postoperative patients with gastric and esophageal cancer have a high risk of tumor recurrence, and traditional imaging methods have certain limitations in early detection of recurrent tumors. Whole-body dynamic <sup>18</sup>F-FDG PET/CT imaging, due to its high sensitivity and specificity, can provide comprehensive information on tumor metabolic activity, which is expected to improve the early diagnosis rate of postoperative recurrent tumors, and provide an important reference for clinical treatment decision-making.</p><p><strong>Aim: </strong>To investigate the clinical value of whole-body dynamic <sup>18</sup>F-FDG PET/CT imaging in differentiating anastomotic recurrence and inflammation after the operation of upper digestive tract tumors.</p><p><strong>Methods: </strong>A retrospective analysis was performed on 53 patients with upper digestive tract tumors after operation and systemic dynamic <sup>18</sup>F-FDG PET/CT imaging indicating abnormal FDG uptake by anastomosis, including 29 cases of gastric cancer and 24 cases of esophageal cancer. According to the follow-up results of gastroscopy and other imaging examinations before and after PET/CT examination, the patients were divided into an anastomotic recurrence group and anastomotic inflammation group. Patlak multi-parameter analysis software was used to obtain the metabolic rate (MRFDG), volume of distribution maximum (DVmax) of anastomotic lesions, and MRmean and DVmean of normal liver tissue. The lesion/background ratio (LBR) was calculated by dividing the MRFDG and DVmax of the anastomotic lesion by the MRmean and DVmean of the normal liver tissue, respectively, to obtain LBR-MRFDG and LBR-DVmax. An independent sample <i>t</i> test was used for statistical analysis, and a receiver operating characteristic curve was used to analyze the differential diagnostic efficacy of each parameter for anastomotic recurrence and inflammation.</p><p><strong>Results: </strong>The dynamic <sup>18</sup>F-FDG PET/CT imaging parameters MRFDG, DVmax, LBR-MRFDG, and LBR-DVmax of postoperative anastomotic lesions in gastric cancer and esophageal cancer showed statistically significant differences between the recurrence group and the inflammatory group (<i>P</i> < 0.05). The parameter LBR-MRFDG showed good diagnostic efficacy in differentiating anastomotic inflammation from recurrent lesions. In the gastric cancer group, the area under the curve (AUC) value was 0.935 (0.778, 0.993) when the threshold was 1.83, and in the esophageal cancer group, the AUC value was 1. When 86 is the threshold, the AUC value is 0.927 (0.743, 0.993).</p><p><strong>Conclusion: </strong>Whole-body dynamic <sup>18</sup>F-FDG PET/C
研究背景本研究旨在探讨全身动态18F-氟脱氧葡萄糖(FDG)正电子发射断层扫描/计算机断层扫描(PET/CT)成像在胃癌和食管癌术后消化道复发性吻合口肿瘤中的应用价值。胃癌和食管癌术后患者肿瘤复发的风险很高,而传统的成像方法在早期发现复发肿瘤方面存在一定的局限性。目的:探讨全身动态18F-FDG PET/CT成像在上消化道肿瘤术后吻合口复发与炎症鉴别中的临床价值:方法:对53例上消化道肿瘤术后全身动态18F-FDG PET/CT成像提示吻合口FDG摄取异常的患者进行回顾性分析,其中胃癌29例,食管癌24例。根据 PET/CT 检查前后胃镜和其他影像学检查的随访结果,将患者分为吻合口复发组和吻合口炎症组。使用 Patlak 多参数分析软件得出吻合口病灶的代谢率(MRFDG)、分布容积最大值(DVmax)以及正常肝组织的 MRmean 和 DVmean。病变/背景比(LBR)的计算方法是将吻合口病变的 MRFDG 和 DVmax 分别除以正常肝组织的 MRmean 和 DVmean,得出 LBR-MRFDG 和 LBR-DVmax。采用独立样本t检验进行统计分析,并利用接收者操作特征曲线分析各参数对吻合口复发和炎症的鉴别诊断功效:胃癌和食管癌术后吻合口病变的动态18F-FDG PET/CT成像参数MRFDG、DVmax、LBR-MRFDG和LBR-DVmax在复发组和炎症组之间差异有统计学意义(P<0.05)。LBR-MRFDG参数在区分吻合口炎症和复发病灶方面显示出良好的诊断效果。在胃癌组,当阈值为1.83时,曲线下面积(AUC)值为0.935(0.778,0.993);在食管癌组,AUC值为1,当阈值为86时,AUC值为0.927(0.743,0.993):全身动态 18F-FDG PET/CT 显像可准确鉴别诊断胃癌和食管癌术后吻合口复发和炎症,有望成为上消化道肿瘤患者手术治疗后的有效监测方法。
{"title":"Application of <sup>18</sup>F-fluorodeoxyglucose positron emission tomography/computed tomography imaging in recurrent anastomotic tumors after surgery in digestive tract tumors.","authors":"Deng-Feng Ge, Hao Ren, Zi-Chen Yang, Shou-Xiang Zhao, Zhen-Ting Cheng, Da-Da Wu, Bin Zhang","doi":"10.4240/wjgs.v16.i8.2474","DOIUrl":"10.4240/wjgs.v16.i8.2474","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;This study was to investigate the application value of whole-body dynamic &lt;sup&gt;18&lt;/sup&gt;F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) imaging in recurrent anastomotic tumors of digestive tract after gastric and esophageal cancer surgery. Postoperative patients with gastric and esophageal cancer have a high risk of tumor recurrence, and traditional imaging methods have certain limitations in early detection of recurrent tumors. Whole-body dynamic &lt;sup&gt;18&lt;/sup&gt;F-FDG PET/CT imaging, due to its high sensitivity and specificity, can provide comprehensive information on tumor metabolic activity, which is expected to improve the early diagnosis rate of postoperative recurrent tumors, and provide an important reference for clinical treatment decision-making.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Aim: &lt;/strong&gt;To investigate the clinical value of whole-body dynamic &lt;sup&gt;18&lt;/sup&gt;F-FDG PET/CT imaging in differentiating anastomotic recurrence and inflammation after the operation of upper digestive tract tumors.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A retrospective analysis was performed on 53 patients with upper digestive tract tumors after operation and systemic dynamic &lt;sup&gt;18&lt;/sup&gt;F-FDG PET/CT imaging indicating abnormal FDG uptake by anastomosis, including 29 cases of gastric cancer and 24 cases of esophageal cancer. According to the follow-up results of gastroscopy and other imaging examinations before and after PET/CT examination, the patients were divided into an anastomotic recurrence group and anastomotic inflammation group. Patlak multi-parameter analysis software was used to obtain the metabolic rate (MRFDG), volume of distribution maximum (DVmax) of anastomotic lesions, and MRmean and DVmean of normal liver tissue. The lesion/background ratio (LBR) was calculated by dividing the MRFDG and DVmax of the anastomotic lesion by the MRmean and DVmean of the normal liver tissue, respectively, to obtain LBR-MRFDG and LBR-DVmax. An independent sample &lt;i&gt;t&lt;/i&gt; test was used for statistical analysis, and a receiver operating characteristic curve was used to analyze the differential diagnostic efficacy of each parameter for anastomotic recurrence and inflammation.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The dynamic &lt;sup&gt;18&lt;/sup&gt;F-FDG PET/CT imaging parameters MRFDG, DVmax, LBR-MRFDG, and LBR-DVmax of postoperative anastomotic lesions in gastric cancer and esophageal cancer showed statistically significant differences between the recurrence group and the inflammatory group (&lt;i&gt;P&lt;/i&gt; &lt; 0.05). The parameter LBR-MRFDG showed good diagnostic efficacy in differentiating anastomotic inflammation from recurrent lesions. In the gastric cancer group, the area under the curve (AUC) value was 0.935 (0.778, 0.993) when the threshold was 1.83, and in the esophageal cancer group, the AUC value was 1. When 86 is the threshold, the AUC value is 0.927 (0.743, 0.993).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;Whole-body dynamic &lt;sup&gt;18&lt;/sup&gt;F-FDG PET/C","PeriodicalId":23759,"journal":{"name":"World Journal of Gastrointestinal Surgery","volume":"16 8","pages":"2474-2483"},"PeriodicalIF":1.8,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11362925/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142112652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application value of dexmedetomidine in anesthesia for elderly patients undergoing radical colon cancer surgery. 右美托咪定在老年结肠癌根治术麻醉中的应用价值。
IF 1.8 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-08-27 DOI: 10.4240/wjgs.v16.i8.2671
Hui-Min Bu, Min Zhao, Hong-Mei Ma, Xiao-Peng Tian

Background: Colon cancer presents a substantial risk to the well-being of elderly people worldwide. With advancements in medical technology, surgical treatment has become the primary approach for managing colon cancer patients. However, due to age-related physiological changes, especially a decline in cognitive function, older patients are more susceptible to the effects of surgery and anesthesia, increasing the relative risk of postoperative cognitive dysfunction (POCD). Therefore, in the surgical treatment of elderly patients with colon cancer, it is of paramount importance to select an appropriate anesthetic approach to reduce the occurrence of POCD, protect brain function, and improve surgical success rates.

Aim: To explore the value of dexmedetomidine (Dex) in anesthesia for elderly patients undergoing radical colon cancer surgery.

Methods: One hundred and seventeen patients with colon cancer who underwent elective surgery under general anesthesia were selected and divided into two groups: A and B. Group A received Dex before anesthesia induction, and B group received an equivalent amount of normal saline. Changes in the mini-mental state examination, regional cerebral oxygen saturation (rSO2), bispectral index, glucose uptake rate (GluER), lactate production rate (LacPR), serum S100β and neuron-specific enolase (NSE), POCD, and adverse anesthesia reactions were compared between the two groups.

Results: Surgical duration, duration of anesthesia, and intraoperative blood loss were comparable between the two groups (P > 0.05). The overall dosage of anesthetic drugs used in group A, including propofol and remifentanil, was significantly lower than that used in group B (P < 0.05). Group A exhibited higher rSO2 values at the time of endotracheal intubation, 30 min after the start of surgery, and immediately after extubation, higher GluER values and lower LacPR values at the time of endotracheal intubation, 30 min after the start of surgery, immediately after extubation, and 5 min after extubation (P < 0.05). Group A exhibited lower levels of serum S100β and NSE 24 h postoperatively and a lower incidence of cognitive dysfunction on the 1st and 5th postoperative days (P < 0.05).

Conclusion: The use of Dex in elderly patients undergoing radical colon cancer surgery helps maintain rSO2 Levels and reduce cerebral metabolic levels and the incidence of anesthesia- and surgery-induced cognitive dysfunction.

背景:结肠癌对全世界老年人的健康构成了巨大威胁。随着医疗技术的进步,手术治疗已成为治疗结肠癌患者的主要方法。然而,由于与年龄相关的生理变化,尤其是认知功能的下降,老年患者更容易受到手术和麻醉的影响,从而增加了术后认知功能障碍(POCD)的相对风险。因此,在对老年结肠癌患者进行手术治疗时,选择合适的麻醉方法对减少 POCD 的发生、保护脑功能和提高手术成功率至关重要。目的:探讨右美托咪定(Dex)在老年结肠癌根治术麻醉中的应用价值:方法:选取 117 名在全身麻醉下接受择期手术的结肠癌患者,将其分为 A、B 两组:A组在麻醉诱导前服用地塞米松,B组服用等量的生理盐水。比较两组的迷你精神状态检查、区域脑氧饱和度(rSO2)、双谱指数、葡萄糖摄取率(GluER)、乳酸生成率(LacPR)、血清 S100β 和神经元特异性烯醇化酶(NSE)、POCD 和麻醉不良反应的变化:结果:两组的手术时间、麻醉时间和术中失血量相当(P>0.05)。A 组使用的丙泊酚和瑞芬太尼等麻醉药物的总剂量明显低于 B 组(P < 0.05)。A 组在气管插管时、手术开始后 30 分钟和拔管后立即显示出较高的 rSO2 值,在气管插管时、手术开始后 30 分钟、拔管后立即和拔管后 5 分钟显示出较高的 GluER 值和较低的 LacPR 值(P < 0.05)。A组术后24小时血清S100β和NSE水平较低,术后第1天和第5天认知功能障碍发生率较低(P<0.05):结论:对接受结肠癌根治术的老年患者使用 Dex 有助于维持 rSO2 水平,降低脑代谢水平以及麻醉和手术引起的认知功能障碍的发生率。
{"title":"Application value of dexmedetomidine in anesthesia for elderly patients undergoing radical colon cancer surgery.","authors":"Hui-Min Bu, Min Zhao, Hong-Mei Ma, Xiao-Peng Tian","doi":"10.4240/wjgs.v16.i8.2671","DOIUrl":"10.4240/wjgs.v16.i8.2671","url":null,"abstract":"<p><strong>Background: </strong>Colon cancer presents a substantial risk to the well-being of elderly people worldwide. With advancements in medical technology, surgical treatment has become the primary approach for managing colon cancer patients. However, due to age-related physiological changes, especially a decline in cognitive function, older patients are more susceptible to the effects of surgery and anesthesia, increasing the relative risk of postoperative cognitive dysfunction (POCD). Therefore, in the surgical treatment of elderly patients with colon cancer, it is of paramount importance to select an appropriate anesthetic approach to reduce the occurrence of POCD, protect brain function, and improve surgical success rates.</p><p><strong>Aim: </strong>To explore the value of dexmedetomidine (Dex) in anesthesia for elderly patients undergoing radical colon cancer surgery.</p><p><strong>Methods: </strong>One hundred and seventeen patients with colon cancer who underwent elective surgery under general anesthesia were selected and divided into two groups: A and B. Group A received Dex before anesthesia induction, and B group received an equivalent amount of normal saline. Changes in the mini-mental state examination, regional cerebral oxygen saturation (rSO2), bispectral index, glucose uptake rate (GluER), lactate production rate (LacPR), serum S100β and neuron-specific enolase (NSE), POCD, and adverse anesthesia reactions were compared between the two groups.</p><p><strong>Results: </strong>Surgical duration, duration of anesthesia, and intraoperative blood loss were comparable between the two groups (<i>P</i> > 0.05). The overall dosage of anesthetic drugs used in group A, including propofol and remifentanil, was significantly lower than that used in group B (<i>P</i> < 0.05). Group A exhibited higher rSO2 values at the time of endotracheal intubation, 30 min after the start of surgery, and immediately after extubation, higher GluER values and lower LacPR values at the time of endotracheal intubation, 30 min after the start of surgery, immediately after extubation, and 5 min after extubation (<i>P</i> < 0.05). Group A exhibited lower levels of serum S100β and NSE 24 h postoperatively and a lower incidence of cognitive dysfunction on the 1st and 5th postoperative days (<i>P</i> < 0.05).</p><p><strong>Conclusion: </strong>The use of Dex in elderly patients undergoing radical colon cancer surgery helps maintain rSO2 Levels and reduce cerebral metabolic levels and the incidence of anesthesia- and surgery-induced cognitive dysfunction.</p>","PeriodicalId":23759,"journal":{"name":"World Journal of Gastrointestinal Surgery","volume":"16 8","pages":"2671-2678"},"PeriodicalIF":1.8,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11362930/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142112653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
World Journal of Gastrointestinal Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1